Comparative Study
doi: 10.1001/jamainternmed.2013.910.
Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study
- PMID: 23699784
- PMCID: PMC3718306
- DOI: 10.1001/jamainternmed.2013.910
Item in Clipboard
Comparative Study
Serotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study
JAMA Intern Med.
.
No abstract available
Figures
Event-Free Survival for Combined Major Adverse Cardiac Events/Mortality in Three Medication Groups
Similar articles
-
Tapping the potential of isomer science.Behav Healthc Tomorrow. 2002 Feb;11(1):SR30-1. Behav Healthc Tomorrow. 2002. PMID: 11837139 No abstract available.
-
[Serotonin syndrome: a potentially severe side effect of selective serotonin reuptake inhibitors].Dtsch Med Wochenschr. 1997 Nov 28;122(48):1495-9. doi: 10.1055/s-2008-1047791. Dtsch Med Wochenschr. 1997. PMID: 9441139 Review. German. No abstract available.
-
Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).Trials. 2009 Apr 7;10:20. doi: 10.1186/1745-6215-10-20. Trials. 2009. PMID: 19351383 Free PMC article. Clinical Trial.
-
[Withdrawal syndrome after the use of serotonin reuptake inhibitors].Tidsskr Nor Laegeforen. 2000 Mar 20;120(8):913-4. Tidsskr Nor Laegeforen. 2000. PMID: 10795494 Norwegian.
-
[Evidence for psychopharmacological treatment of depression in children and adolescents?].Ugeskr Laeger. 2007 Apr 2;169(14):1289-94. Ugeskr Laeger. 2007. PMID: 17437688 Review. Danish.
Cited by
-
Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Curr Neuropharmacol. 2014 Jul;12(4):365-79. doi: 10.2174/1570159X12666140828221720. Curr Neuropharmacol. 2014. PMID: 25342944 Free PMC article.
-
Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.JAMA. 2018 Jul 24;320(4):350-358. doi: 10.1001/jama.2018.9422. JAMA. 2018. PMID: 30043065 Free PMC article. Clinical Trial.
-
[Treatment of depression in coronary heart disease].Nervenarzt. 2015 Mar;86(3):375-85; quiz 386-7. doi: 10.1007/s00115-014-4162-z. Nervenarzt. 2015. PMID: 25737494 German.
-
Long-term sertraline treatment and depression effects on carotid artery atherosclerosis in premenopausal female primates.Menopause. 2017 Oct;24(10):1175-1184. doi: 10.1097/GME.0000000000000916. Menopause. 2017. PMID: 28609387 Free PMC article.
-
Serotonin: a platelet hormone modulating cardiovascular disease.J Thromb Thrombolysis. 2021 Jul;52(1):42-47. doi: 10.1007/s11239-020-02331-0. Epub 2020 Nov 5. J Thromb Thrombolysis. 2021. PMID: 33155668 Free PMC article. Review.
References
-
- Kent LK, Shapiro PA. Depression and related psychological factors in heart disease. Harv Rev Psychiatry. 2009;17:377–388. - PubMed
-
- Lichtman JH, Bigger JT, Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–1775. - PubMed
-
- de Abajo FJ, Montero D, Rodriguez LA, Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol. 2006;98:304–310. - PubMed
-
- FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide) 2011 Available at http://www.fda.gov/Drugs/DrugSafety/ucm269086.htm.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
